131 related articles for article (PubMed ID: 38112689)
1. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
3. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis.
Freytag JO; Queiroz MR; Govoni VM; Pereira IVA; Pulz LH; de Francisco Strefezzi R; Queiroga FL; Cogliati B
Vet Comp Oncol; 2021 Sep; 19(3):529-540. PubMed ID: 33724647
[TBL] [Abstract][Full Text] [Related]
5. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
6. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
7. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours.
Barra CN; Macedo BM; Cadrobbi KG; Pulz LH; Huete GC; Kleeb SR; Xavier JG; Catão-Dias JL; Nishiya AT; Fukumasu H; Strefezzi RF
Vet Comp Oncol; 2018 Mar; 16(1):E38-E44. PubMed ID: 28608404
[TBL] [Abstract][Full Text] [Related]
9. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
10. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
[TBL] [Abstract][Full Text] [Related]
11. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
12. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
Sledge DG; Webster J; Kiupel M
Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
[TBL] [Abstract][Full Text] [Related]
13. Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours.
van Lelyveld S; Warland J; Miller R; Maw H; Foale R; Goodfellow M; Dobson J
J Small Anim Pract; 2015 May; 56(5):312-9. PubMed ID: 25728289
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous mastocytosis in 8 young dogs and review of literature.
Yang C; Bradley CW; Preziosi D; Mauldin EA
Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
[TBL] [Abstract][Full Text] [Related]
15. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.
Kiupel M; Camus M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):819-836. PubMed ID: 31178200
[TBL] [Abstract][Full Text] [Related]
17. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
[TBL] [Abstract][Full Text] [Related]
18. Internal Tandem Duplication of Exon 8 of
Brocks BAW; Bertram CA; Bartel A; Kirpensteijn J; Collins-Webb A; Catlin C; Thaiwong T; Kiupel M
Vet Pathol; 2021 Mar; 58(2):315-324. PubMed ID: 33231140
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
20. Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors.
Casanova M; Branco S; Veiga IB; Barros A; Faísca P
Vet Pathol; 2021 May; 58(3):483-490. PubMed ID: 33576305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
